巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Scholar Rock Holding Corp

    SRRK
    11.290
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Scholar Rock Holding Corp - 延遲價格・最後更新於 15/08 22:00
    最高位
    --
    最低位
    --
    開市價
    --
    前收市價
    11.290
    成交量(千)
    --
    成交額(百萬)
    --
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    583.02
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    44.950 - 4.325
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Scholar Rock Holding Corp
    證券代碼
    SRRK.US
    所屬板塊
    Biotechnology
    公司業務
    Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle.
    發行量
    35297455
    公司總部
    301 Binney Street, 3rd Floor
    公司網址
    https://www.scholarrock.com
    公司電郵
    chu@scholarrock.com
    公司電話
    +1 857 259-3860
    暫無內容

    關於

    Scholar Rock Holding Corp(SRRK.US)所屬的行業板塊為Biotechnology。
    Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle.
    詳細公司背景可參考: https://www.scholarrock.com